Brachial endothelial function in subjects with familial combined hyperlipidemia and its relationships to carotid artery intima-media thickness

International Angiology

Volumn 25, Issue 4, 2006, Pages 418-426

  Karásek, David ^a   Vaverkova H ^a   Halenka, M ^a   Budikova M ^a   Novotny, D ^a  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

Flow mediated dilatation; Hyperlipidemia, familial combined; Tunica intima; Tunica media

Indexed keywords

APOLIPOPROTEIN B; C PEPTIDE; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROINSULIN; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BRACHIAL ARTERY; COMMON CAROTID ARTERY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FAMILIAL HYPERLIPEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPEREMIA; INSULIN RESISTANCE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROTEIN BLOOD LEVEL; RELATIVE; RISK FACTOR; SEX DIFFERENCE; TUNICA MEDIA;

ADULT; BRACHIAL ARTERY; FEMALE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; TUNICA INTIMA; TUNICA MEDIA;

EID: 33847627861     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a now inherited disorder, combined hyperlipidemia. J Clin Invest 1973;52:1544-68.
2. Vaverková H, Weinbergová O, Horika V, Kubata M, Vrublovk P. Familial combined hyperlipidemia. Part II. Clinical picture. Acta Univ Palacki 1986;114:243-59.
3. Venkatesan S, Cullen P, Pacy P, Halliday D, Scott J. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler Thromb 1993;13:110-8.
4. Hokanson JE, Austin MA, Zambon A, Brunzell JD. Plasma triglyceride and LDL heterogeneity in familial combined hyperlipidemia. Arteriocler Thromb 1993;13:427-34.
5. Hokanson JE, Krauss RM, Albers JJ, Austin MA, Brunzell JD. LDL physical and chemical properties in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 1995;15:452-9.
6. de Graaf J, Stalenhoef AF. Defects of lipoprotein metabolism in familial combined hyperlipidemia. Curr Opin Lipidol 1998;9:189-96.
7. Keulen ET, Voors-Pette C, de Bruin TW. Familial dyslipidemic hypertension syndrome: familial combined hyperlipidemia, and the role of abdominal fat mass. Am J Hypertens 2001;14:357-63.
8. Raitakari OT, Celermajer DS. Flow mediated dilatation. Br J Clin Pharmacol 2000;50:397-404.
9. Vogel RA. Brachial artery ultrasound: a non-invasive tool in the assessment of triglyceride-rich lipoproteins. Clin Cardiol 1999;22 Suppl 2:34-9.
10. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899-906.
11. Kuvin JT, Patel AR, Sliney KA, Pandian NG, Rand WM, Udelson JE et al. Peripheral vascular endothelial function testing as a noninvasive indicator of coronary artery disease. J Am Coll Cardiol 2001;38:1843-9.
12. Schroder S, Enderle MD, Meisner C, Baumbach A, Herdeg C, Oberhoff M et al. The ultrasonic measurement of the endothelial function of the brachial artery in suspected coronary heart disease. Dtsch Med Wochenschr 1999;124:886-90.
13. Neunteufl T, Heher S, Katzenschlager R, Wolff G, Kostner K, Maurer G et al. Late prognostic value of flow-mediated dilatation in the brachial artery of patients with chest pain. Am J Cardiol 2000;86:207-10.
14. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995;26:1235-41.
15. Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 1991;229:225-31.
16. Sharrett AR, Patsch W, Sorlie PD, Heiss G, Bond MG, Davis CE. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 1994;14:1098-104.
17. Geroulakos G, O'Gorman DJ, Kalodiki E, Sheridan DJ, Nicolaides AN. The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J 1994;15:781-5.
18. Visona A, Pesavento R, Lusiani L, Bonanome A, Cernetti C, Rossi M et al. Intimal medial thickening of common carotid artery as indicator of coronary artery disease. Angiology 1996;47:61-6.
19. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96:1432-7.
20. Bonithon-Kopp C, Touboul PJ, Berr C, Leroux C, Mainard F, Courbon D et al. Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. The Vascular Aging (EVA) Study. Arterioscler Thromb Vasc Biol 1996;16:310-6.
21. Rosfors S, Hallerstam S, Jensen-Urstad K, Zetterling M, Carlstrom C. Relationship between intima-media thickness in the common carotid artery and atherosclerosis in the carotid bifurcation. Stroke 1998;29:1378-82.
22. Bots ML, Hofman A, Grobbee DE. Common carotid intima-media thickness and lower extremity arterial atherosclerosis. The Rotterdam Study. Arterioscler Thromb 1994;14:1885-91.
23. Bots ML, de Jong PT, Hofman A, Grobbee DE. Left, right, near or far wall common carotid intima-media thickness measurements: associations with cardiovascular disease and lower extremity arterial atherosclerosis. J Clin Epidemiol 1997;50:801-7.
24. Keulen ET, Kruijshoop M, Schaper NC, Hoeks AP, de Bruin TW. Increased intima-media thickness in familial combined hyperlipidemia associated with apolipoprotein B. Arterioscler Thromb Vasc Biol 2002;22:283-8.
25. Ylitalo K, Syvanne M, Salonen R, Nuotio I, Taskinen MR, Salonen JT. Carotid artery intima-media thickness in Finnish families with familial combined hyperlipidemia. Atherosclerosis 2002;162:171-8.
26. Halenka M, Vaverkova H, Hutyra M, Karasek D, Slavik L, Novotny D et al. Detection of early atherosclerosis using the ultrasound parameter of the intima-media thickness of the common carotid artery in families with familial combined hyperlipidemia. Int Angiol 2004;23:230-7.
27. Cifkova R, Skodova Z, Poledne R, Adamkova V, Novozamska E, Jozifova M et al. [Longitudinal trends of total and HDL-cholesterol in a representative population ample of Czech republic]. Vnitr Lek 2000;9:501-5.
28. Demacker PN, Veerkamp MJ, Bredie, SJ, Marcovina SM, de Graaf J, Stalenhoef AF. Comparison of the measurement of lipids and lipoproteins versus assay of apolipoprotein B for estimation of coronary heart disease risk: a study in familial combined hyperlipidemia. Atherosclerosis 2000;153:483-90.
29. Veerkamp MJ, de Graaf J, Bredie SJ, Hendriks JC, Demacker PN, Stalenhoef AF. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study. Arterioscler Thromb Vasc Biol 2002;22:274-82.
30. Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem 2001;34:583-8.
31. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
32. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-5.
33. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA et al.; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-65. Erratum in: J Am Coll Cardiol 2002;39:1082.
34. ter Avest E, Abbink EJ, Holewijn S, de Graaf J, Tack CJ, Stalenhoef AF. Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH). Curr Med Res Opin 2005;21:1469-76.
35. Malik J, Melenovsky V, Wichterle D, Haas T, Simek J, Ceska R et al. Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial - FAT). Cardiovasc Res 2001;52:290-8.
36. Sebestjen M, Zegura B, Keber I. Both cerivastatin and fenofibrate improve arterial vasoreactivity in patients with combined hyperlipidaemia. J Intern Med 2002;251:77-85.
37. Wang TD, Chen WJ, Lin JW, Cheng CC, Chen MF, Lee YT. Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles. Atherosclerosis 2003;170:315-23.
38. Kovacs I, Toldy E, Abel T, Tarjan J, Csaszar A. The effect of ciprofibrate on flow-mediated dilation and inflammatory markers in patients with combined hyperlipidemia. Endothelium 2005;12:179-83.
39. Stroes E, de Bruin T, de Valk H, Erkelens W, Banga JD, van Rijn H et al. NO activity in familial combined hyperlipidemia: potential role of cholesterol remnants. Cardiovasc Res 1997;36:445-52.
40. Pitkanen OP, Nuutila P, Raitakari OT, Porkka K, Iida H, Nuotio I et al. Coronary flow reserve in young men with familial combined hyperlipidemia. Circulation 1999;99:1678-84.
41. Karasek D, Vaverkova H, Halenka M, Budikova M, Novotny D. Soluble cell adhesion molecules s-VCAM-1 and s-ICAM-1 in subjects with familial combined hyperlipidemia. Biomed Pap Med Fac Univ Palacky 2005;149:101-8.
42. Vakkilainen J, Porkka KV, Nuotio I, Pajukanta P, Suurinkeroinen L, Ylitalo K et al. Glucose intolerance in familial combined hyperlipidaemia. EUFAM study group. Eur J Clin Invest 1998;28:24-32.
43. Pihlajamaki J, Karjalainen L, Karhapaa P, Vauhkonen I, Laakso M. Impaired free fatty acid suppression during hyperinsulinemia is a characteristic finding in familial combined hyperlipidemia, but insulin resistance is observed only in hypertriglyceridemic patients. Arterioscler Thromb Vasc Biol 2000;20:164-70.
44. Clarkson P, Celermajer DS, Powe AJ, Donald AE, Henry RM, Deanfield JE. Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary disease. Circulation 1997;96:3378-83.
45. Balletshofer BM, Rittig K, Enderle MD, Volk A, Maerker E, Jacob S et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 2000;101:1780-4.
46. Campia U, Sullivan G, Bryant MB, Waclawiw MA, Quon MJ, Panza JA. Insulin impairs endothelium-dependent vasodilation independent of insulin sensitivity or lipid profile. Am J Physiol Heart Circ Physiol 2004;286:H76-82.
47. Balletshofer BM, Rittig K, Stock J, Lehn-Stefan A, Overkamp D, Dietz K et al. Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness. Atherosclerosis 2003;171:303-9.
48. Suzuki M, Takamisawa I, Suzuki K, Hiuge A, Horio T, Yoshimasa Y et al. Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension. Am J Hypertens 2004;17:228-32.
49. Ardigo D, Franzini L, Valtuena S, Monti LD, Reaven GM, Zavaroni I. Relation of plasma insulin levels to forearm flow-mediated dilatation in healthy volunteers. Am J Cardiol 2006;97:1250-4.
50. Juonala M, Viikari JS, Laitinen T, Marniemi J, Helenius H, Ronnemaa T et al. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study. Circulation 2004;110:2918-23.
51. Hashimoto M, Eto M, Akishita M, Kozaki K, Ako J, Iijima K et al. Correlation between flow-mediated vasodilatation of the brachial artery and intima-media thickness in the carotid artery in men. Arterioscler Thromb Vasc Biol 1999;19:2795-800.
52. Ravikumar R, Deepa R, Shanthirani C, Mohan V. Comparison of carotid intima-media thickness, arterial stiffness, and brachial artery flow mediated dilatation in diabetic and nondiabetic subjects (The Chennai Urban Population Study [CUPS-9]). Am J Cardiol 2002;90:702-7.
53. Barenbrock M, Hausberg M, Kosch M, Golubev SA, Kisters K, Rahn KH. Flow-mediated vasodilation and distensibility in relation to intima-media thickness of large arteries in mild essential hypertension. Am J Hypertens 1999;12:973-9.